Want to see CH:SKAN full AI Analyst Report?
SKAN Stock Chart & Stats
CHF65.70
CHF1.00(1.75%)
At close: 4:00 PM EDT
CHF65.70
CHF1.00(1.75%)
Day’s Range― - ―
52-Week RangeCHF35.75 - CHF70.70
Previous CloseN/A
Volume14.18K
Average Volume (3M)50.59K
Market Cap
CHF1.59B
Enterprise ValueCHF1.30K
Total Cash (Recent Filing)CHF88.47M
Total Debt (Recent Filing)CHF130.63M
Price to Earnings (P/E)51.7
Beta1.05
Next Earnings
Mar 23, 2027EPS Estimate
1.33Next Dividend Ex-DateN/A
Dividend Yield0.32%
Share Statistics
EPS (TTM)1.33
Shares Outstanding22,483,524
10 Day Avg. Volume70,057
30 Day Avg. Volume50,592
Financial Highlights & Ratios
PEG Ratio-1.26
Price to Book (P/B)10.37
Price to Sales (P/S)3.56
P/FCF Ratio56.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.38
Revenue Forecast (FY)CHF395.52M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthThe sharp 2025 rebound and strong multi-year revenue trajectory indicate continued demand for SKAN’s aseptic manufacturing solutions. Sustained top-line expansion can broaden the installed base, support future service revenue, and reinforce the company’s position in regulated pharmaceutical production.
High Gross MarginsConsistently high gross margins suggest SKAN’s specialized equipment, systems, and regulated-industry expertise provide meaningful economic value. This margin structure creates room to fund engineering, service capabilities, and customer support while preserving earnings potential through different demand cycles.
Improved Cash GenerationThe return to positive free cash flow and stronger operating cash generation improves SKAN’s ability to finance operations and investment internally. Although conversion remains uneven, this improvement provides a more supportive foundation for servicing customers, developing solutions, and managing the installed base.
Bears Say
Sharp Leverage IncreaseThe substantial increase in leverage materially reduces financial flexibility compared with SKAN’s historically low-debt position. Higher debt relative to equity can increase financing pressure and constrain investment capacity if operating performance remains volatile or the business requires additional capital.
Profitability DeteriorationThe decline in operating and net margins shows that strong revenue growth did not translate proportionally into earnings in 2025. If sustained, weaker profitability could reduce internal funding capacity, limit the benefits of scale, and make the business more sensitive to execution and cost pressures.
Volatile Free Cash Flow ConversionUneven free cash flow and weak conversion of 2025 net income indicate that accounting earnings have not consistently translated into deployable cash. This can complicate investment planning and debt management, particularly after the recent increase in leverage and during project-driven revenue cycles.
SKAN Group AG News
SKAN FAQ
What was SKAN Group AG’s price range in the past 12 months?
SKAN Group AG lowest stock price was CHF35.75 and its highest was CHF70.70 in the past 12 months.
What is SKAN Group AG’s market cap?
SKAN Group AG’s market cap is CHF1.59B.
When is SKAN Group AG’s upcoming earnings report date?
SKAN Group AG’s upcoming earnings report date is Mar 23, 2027 which is in 171 days.
How were SKAN Group AG’s earnings last quarter?
SKAN Group AG released its earnings results on Aug 18, 2026. The company reported CHF0.214 earnings per share for the quarter.
Is SKAN Group AG overvalued?
According to Wall Street analysts SKAN Group AG’s price is currently Overvalued.
Does SKAN Group AG pay dividends?
SKAN Group AG pays a Annually dividend of CHF0.22 which represents an annual dividend yield of 0.32%. See more information on SKAN Group AG dividends here
What is SKAN Group AG’s EPS estimate?
SKAN Group AG’s EPS estimate is 1.33.
How many shares outstanding does SKAN Group AG have?
SKAN Group AG has 22,483,524 shares outstanding.
What happened to SKAN Group AG’s price movement after its last earnings report?
SKAN Group AG reported an EPS of CHF0.214 in its last earnings report. Following the earnings report the stock price went up 2.253%.
Which hedge fund is a major shareholder of SKAN Group AG?
Currently, no hedge funds are holding shares in CH:SKAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SKAN Group AG
SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company operates through two distinct divisions: Equipment and Solutions (E&S), and Services and Consumables (S&C). Its E&S segment delivers essential products for pharmaceutical manufacturing, including high-tech isolators, integrated automated systems, aseptic filling solutions, and specialized laboratory and cleanroom equipment. Meanwhile, the S&C segment focuses on providing comprehensive life cycle support, ready-to-use consumables, and custom digital and client-specific solutions. Founded in 1968, the company, which changed its name from BV Holding AG to SKAN Group AG in October 2021, is headquartered in Allschwil, Switzerland.